Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.
|
Nat Rev Drug Discov
|
2006
|
2.84
|
2
|
Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy.
|
Nat Protoc
|
2007
|
2.84
|
3
|
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
|
J Am Coll Cardiol
|
2007
|
2.81
|
4
|
Simple quantitative detection of mitochondrial superoxide production in live cells.
|
Biochem Biophys Res Commun
|
2007
|
2.51
|
5
|
CD39 and CD73 in immunity and inflammation.
|
Trends Mol Med
|
2013
|
2.08
|
6
|
Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism.
|
J Immunol
|
2005
|
1.98
|
7
|
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
|
Crit Care Med
|
2002
|
1.97
|
8
|
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.
|
FASEB J
|
2007
|
1.94
|
9
|
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
|
Am J Physiol Heart Circ Physiol
|
2009
|
1.89
|
10
|
CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.77
|
11
|
A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli.
|
Blood
|
2007
|
1.76
|
12
|
Immunity, inflammation and cancer: a leading role for adenosine.
|
Nat Rev Cancer
|
2013
|
1.69
|
13
|
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure.
|
Am J Physiol Heart Circ Physiol
|
2004
|
1.67
|
14
|
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
|
J Am Coll Cardiol
|
2010
|
1.56
|
15
|
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.54
|
16
|
Investigational A₃ adenosine receptor targeting agents.
|
Expert Opin Investig Drugs
|
2011
|
1.49
|
17
|
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis.
|
Eur J Pharmacol
|
2003
|
1.48
|
18
|
Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.
|
J Immunol
|
2006
|
1.43
|
19
|
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.
|
J Leukoc Biol
|
2007
|
1.39
|
20
|
Adenosine promotes alternative macrophage activation via A2A and A2B receptors.
|
FASEB J
|
2011
|
1.38
|
21
|
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
|
Free Radic Biol Med
|
2009
|
1.38
|
22
|
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.34
|
23
|
A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.
|
J Immunol
|
2010
|
1.33
|
24
|
A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.
|
J Pharmacol Exp Ther
|
2004
|
1.32
|
25
|
Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.
|
Am J Respir Crit Care Med
|
2002
|
1.31
|
26
|
Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells.
|
J Cell Physiol
|
2004
|
1.28
|
27
|
Adenosine receptor activation ameliorates type 1 diabetes.
|
FASEB J
|
2007
|
1.27
|
28
|
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
|
Free Radic Biol Med
|
2011
|
1.24
|
29
|
Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death.
|
J Pharmacol Exp Ther
|
2008
|
1.24
|
30
|
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
|
Cardiovasc Res
|
2009
|
1.22
|
31
|
Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.
|
Int J Mol Med
|
2006
|
1.21
|
32
|
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.
|
Br J Pharmacol
|
2010
|
1.18
|
33
|
Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.
|
FASEB J
|
2008
|
1.16
|
34
|
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
|
Diabetes
|
2012
|
1.10
|
35
|
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.
|
Hepatology
|
2014
|
1.09
|
36
|
Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism.
|
Biochem Biophys Res Commun
|
2003
|
1.08
|
37
|
Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells.
|
Am J Pathol
|
2002
|
1.08
|
38
|
Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury.
|
Ann Surg
|
2002
|
1.07
|
39
|
Lithium induces NF-kappa B activation and interleukin-8 production in human intestinal epithelial cells.
|
J Biol Chem
|
2001
|
1.06
|
40
|
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.
|
J Cell Mol Med
|
2008
|
1.05
|
41
|
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis.
|
Biochem Biophys Res Commun
|
2006
|
1.04
|
42
|
Trauma/hemorrhagic shock mesenteric lymph upregulates adhesion molecule expression and IL-6 production in human umbilical vein endothelial cells.
|
Shock
|
2002
|
1.03
|
43
|
Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation.
|
J Immunol
|
2012
|
1.02
|
44
|
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.
|
Free Radic Biol Med
|
2010
|
1.01
|
45
|
Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency.
|
J Leukoc Biol
|
2008
|
1.01
|
46
|
Trauma-hemorrhagic shock mesenteric lymph induces endothelial apoptosis that involves both caspase-dependent and caspase-independent mechanisms.
|
Ann Surg
|
2004
|
1.00
|
47
|
Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death.
|
FASEB J
|
2010
|
1.00
|
48
|
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.
|
Trends Pharmacol Sci
|
2009
|
0.99
|
49
|
Hemorrhagic shock induces endothelial cell apoptosis, which is mediated by factors contained in mesenteric lymph.
|
Crit Care Med
|
2004
|
0.98
|
50
|
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.
|
Br J Pharmacol
|
2010
|
0.97
|
51
|
Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation.
|
Biochem Biophys Res Commun
|
2008
|
0.96
|
52
|
Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists.
|
J Leukoc Biol
|
2009
|
0.96
|
53
|
Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process.
|
J Immunol
|
2011
|
0.94
|
54
|
CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.
|
PLoS One
|
2009
|
0.94
|
55
|
Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.
|
Biochem Biophys Res Commun
|
2006
|
0.93
|
56
|
NHE blockade inhibits chemokine production and NF-kappaB activation in immunostimulated endothelial cells.
|
Am J Physiol Cell Physiol
|
2002
|
0.93
|
57
|
Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.
|
Mol Med
|
2003
|
0.93
|
58
|
Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices.
|
J Neuroimmunol
|
2004
|
0.92
|
59
|
Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
|
Gastroenterology
|
2013
|
0.92
|
60
|
Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale.
|
Inflammation
|
2005
|
0.92
|
61
|
Na+/H+ exchanger blockade inhibits enterocyte inflammatory response and protects against colitis.
|
Am J Physiol Gastrointest Liver Physiol
|
2002
|
0.90
|
62
|
A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation.
|
Diabetes
|
2013
|
0.90
|
63
|
The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.
|
Am J Pathol
|
2011
|
0.89
|
64
|
Adenosine, inflammation pathways and therapeutic challenges.
|
Joint Bone Spine
|
2011
|
0.89
|
65
|
Female X-chromosome mosaicism for NOX2 deficiency presents unique inflammatory phenotype and improves outcome in polymicrobial sepsis.
|
J Immunol
|
2011
|
0.88
|
66
|
Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
|
Mol Pharmacol
|
2004
|
0.87
|
67
|
Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages.
|
J Leukoc Biol
|
2013
|
0.86
|
68
|
Role of A(2A) adenosine receptors in regulation of opsonized E. coli-induced macrophage function.
|
Purinergic Signal
|
2007
|
0.86
|
69
|
Amiloride moderates increased gut permeability and diminishes mesenteric lymph-mediated priming of neutrophils in trauma/hemorrhagic shock.
|
Surgery
|
2006
|
0.86
|
70
|
Calcium entry inhibition during resuscitation from shock attenuates inflammatory lung injury.
|
Shock
|
2008
|
0.84
|
71
|
Na+,K+-ATPase activity is inhibited in cultured intestinal epithelial cells by endotoxin or nitric oxide.
|
Int J Mol Med
|
2005
|
0.84
|
72
|
Endothelial Nrf2 activation: a new target for resveratrol?
|
Am J Physiol Heart Circ Physiol
|
2010
|
0.84
|
73
|
Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death.
|
Free Radic Biol Med
|
2012
|
0.83
|
74
|
Amiloride combined with small-volume resuscitation with hypertonic saline is superior in ameliorating trauma-hemorrhagic shock-induced lung injury in rats to the administration of either agent alone.
|
Crit Care Med
|
2005
|
0.83
|
75
|
Pyrrolidinedithiocarbamate inhibits NF-kappaB activation and IL-8 production in intestinal epithelial cells.
|
Immunol Lett
|
2003
|
0.82
|
76
|
Female X-chromosome mosaicism for gp91phox expression diversifies leukocyte responses during endotoxemia.
|
Crit Care Med
|
2010
|
0.82
|
77
|
Adenosine pathway and cancer: where do we go from here?
|
Expert Opin Ther Targets
|
2014
|
0.81
|
78
|
3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism.
|
Biochim Biophys Acta
|
2012
|
0.80
|
79
|
Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury.
|
Purinergic Signal
|
2013
|
0.78
|
80
|
Role of nonsynaptic communication in regulating the immune response.
|
Neurochem Int
|
2007
|
0.77
|
81
|
Cytoprotective dibenzoylmethane derivatives protect cells from oxidative stress-induced necrotic cell death.
|
Pharmacol Res
|
2013
|
0.76
|
82
|
Suppression of tumorigenicity 2: a janus-faced player in sepsis.
|
Am J Respir Crit Care Med
|
2011
|
0.75
|